Results for tag: "Androgen Antagonist"

The Androgen Antagonist market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat conditions such as prostate cancer, hirsutism, and polycystic ovary syndrome. Androgen antagonists work by blocking the action of androgens, which are hormones that can cause the growth of certain types of cancer cells. They can also be used to reduce the production of androgens in the body, which can help to reduce symptoms of hirsutism and polycystic ovary syndrome. The Androgen Antagonist market is highly competitive, with a number of companies offering products for the treatment of endocrine and metabolic disorders. Some of the major players in the market include AstraZeneca, Pfizer, Merck, Novartis, and Sanofi. These companies offer a range of products, including oral medications, injectables, and topical treatments. Show Less Read more